Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery

NCT02152761 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscle Wasting (Atrophy) After Hip Fracture Surgery

Interventions

DRUG: bimagrumab
OTHER: placebo

Sponsor

Novartis Pharmaceuticals